PDF(Pubmed)
Abstract：
UNASSIGNED: Clinical presentation of leukemia cutis (LC) is polymorphic and can reveal a malignant hemopathy. More commonly described in cases of acute myeloid leukemia (AML), LC can also occur in case of chronic myeloid leukemia (CML).
UNASSIGNED: Leukemia cutis is a rare form of extramedullary feature of malignant hemopathy, seldom associated with CML. Its clinical presentation is pleiotropic and differential diagnosis is broad. It relies on clinical and typical histological and biomolecular concordance. Once confirmed, treatment is based on that of the primary condition. We present a case of a leukemia cutis revealing a relapse of a CML successfully treated by tyrosine kinase inhibitor.
UNASSIGNED: Leukemia cutis is a rare form of extramedullary feature of malignant hemopathy, seldom associated with CML. Its clinical presentation is pleiotropic and differential diagnosis is broad. It relies on clinical and typical histological and biomolecular concordance. Once confirmed, treatment is based on that of the primary condition. We present a case of a leukemia cutis revealing a relapse of a CML successfully treated by tyrosine kinase inhibitor.
摘要：
■皮肤白血病（LC）的临床表现是多态的，可以揭示恶性血液病。更常见于急性髓细胞性白血病（AML），LC也可在慢性髓性白血病(CML)的情况下发生。
■皮肤白血病是一种罕见的恶性血液病的髓外特征，很少与CML相关。其临床表现为多效性，鉴别诊断广泛。它依赖于临床和典型的组织学和生物分子一致性。一旦确认,治疗是基于主要条件。我们介绍了一例皮肤白血病，揭示了酪氨酸激酶抑制剂成功治疗的CML复发。
■皮肤白血病是一种罕见的恶性血液病的髓外特征，很少与CML相关。其临床表现为多效性，鉴别诊断广泛。它依赖于临床和典型的组织学和生物分子一致性。一旦确认,治疗是基于主要条件。我们介绍了一例皮肤白血病，揭示了酪氨酸激酶抑制剂成功治疗的CML复发。
